Log in
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Dynamic quotes 

MarketScreener Homepage  >  Equities  >  Nyse  >  The Procter & Gamble Company    PG


SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

SANUWAVE CEO To Present At "The Global Chinese Financial Forum" Thursday, September 10, 2020; Message Targets Transformative Acquisition Of Celularity's UltraMIST®

share with twitter share with LinkedIn share with facebook
09/10/2020 | 04:34am EDT

SANUWAVE (OTCMKTS: SNWV) CEO Kevin Richardson II is back on the road following last week's presentation at the LD Micro 500 virtual conference. On Thursday, September 10, 2020, Mr. Richardson will be presenting at The Global Chinese Financial Forum at 11:15 am PST (2:15 pm ET). The event will include a formal corporate presentation and one-on-one investor meetings.

The presentation is expected to detail how the addition of Celularity's UltraMIST® is a transformative event for SANUWAVE. The remaining three investor presentations planned for September will likely follow a similar theme- the acquisition created a transformative and game-changing moment for SANUWAVE.

Following the conclusion of the LD Micro event, shares of SANUWAVE traded higher by more than 5% as investors digested the news that more than $15 million in accretive revenues and $4 million in EBITDA will likely be added to its yearly run-rate. The company also noted that it is well into the process of listing to a more senior exchange with an update expected in the next thirty days.

At the LD conference, SANUWAVE discussed the value drivers behind the UltraMIST® acquisition. Besides the immediately accretive acquisition of UltraMIST®, the company also secured premium licensing terms for two important biologics, Biovance and Interfyl, creating a comprehensive wound-care treatment platform that can effectively treat patients from discovery to closure. Additionally, an enhanced and trained sales force of roughly 100 people can immediately maximize and cross-sell the combined strength and complementary nature of UltraMIST® and dermaPACE®, SANUWAVE's flagship device.

SANUWAVE expects to seize the cross-selling opportunities from roughly 1000 customer accounts with only 15 that overlap to create a ramp in revenues in the current quarter. Moreover, revenue growth is expected to accelerate in the coming quarters and benefit from cost savings and economies of scale. In the Q&A following the presentation, Mr. Richardson said that he believes the company can reach a $100 million revenue run rate in roughly three years.

Following tomorrow's event, SANUWAVE will be at the HC Wainwright 22nd Annual Global Investment Conference on Wednesday, September 16, 2020, and will present at 4:00 pm ET. (see schedule and link to all events below)

Busy Presentation Schedule In September

SANUWAVE is scheduled to present at four major virtual investor conferences this month. The message is expected to help investors understand the true value behinds this game-changing acquisition for SANUWAVE. It may also tighten the valuation disconnect between current stock price levels that neglect the enormous boost to revenues and EBITDA earnings.

The September 2020 presentation schedule includes:

Completed - The LD Micro 500 - Listen to the presentation HERE

Dates: September 1 - 4, 2020

Company presentation: Wednesday, September 2, 2020, at 8:40 am ET

Format: Corporate presentation and One-on-One Investor Meetings

The Global Chinese Financial Forum-Investing in Innovation

Dates: September 10, 2020

Company presentation: Thursday, September 10, 2020, at 11:15 am PST (2:15 pm ET)

Format: Corporate presentation and One-on-One Investor Meetings

HC Wainwright 22nd Annual Global Investment Conference

Dates: September 15-16, 2020

Company Presentation: Wednesday, September 16, 2020, at 4:00 pm ET

Format: Corporate presentation and One-on-One Investor Meetings

Lake Street Capital Markets 4th Annual Best Ideas Growth Conference (Big 4)

Dates: September 17, 2020

Format: One-on-One Investor Meetings

Each presentation will be webcast live and is accessible through the Events section of SANUWAVE Health's website at www.SANUWAVE.com, where they will also be archived.

SANUWAVE's message is one of transformation for the company. The virtual conferences provide a forum for SANUWAVE to highlight the substantial growth opportunities inherent to its acquisition of Celularity's UltraMIST® assets. Further, SANUWAVE can show competitive differences and advantages compared to industry giants like Procter & Gamble (NYSE: PG) and Medtronic (NYSE: MDT). Medtronic reported revenues of more than $550 million from its diabetes group during its recently completed quarter, a number that demonstrates just a portion of the market opportunities for SANUWAVE.

The message delivered at LD Micro was powerful. Simply stated, management explained that the transformative acquisition provides SANUWAVE with a platform of scale, immediately brings substantial recurring revenue, and gives SANUWAVE an end-to-end advanced wound care product portfolio. The entirety of that platform addresses the entire care pathway and is compelling to patients, providers, and payers.

Few, if any, other companies in the sector currently offer such a comprehensive treatment solution.

Disclaimers: Blue Hawk Media, LLC is not operated by a licensed broker, a dealer, or a registered investment adviser. It should be expressly understood that under no circumstances does any information published herein represent a recommendation to buy or sell a security. The information made available by Blue Hawk Media, LLC is not intended to be, nor does it constitute, investment advice or recommendations. The contributors may buy and sell securities before and after any particular article, report and publication. In no event shall Blue Hawk Media, LLC be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or made available by Blue Hawk Media, LLC, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information in this video, article, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. This video and its release is to syndicated outlets has been produced through the engagement of a third party, SANUWAVE, Inc., who has hired Blue Hawk Media, LLC to prepare a research and video report for SANUWAVE. The company has compensated Blue Hawk Media, LLC three-thousand-five-hundred dollars to prepare original content, video production , and syndication services.

Media Contact

Company Name: Blue Hawk Media, LLC

Contact Person: Kenny Ellis

Email: editorial@soulstringmedia.com

Country: United States

Website: https://www.soulstringmedia.com

Source: www.abnewswire.com


(C) 2020 M2 COMMUNICATIONS, source M2 PressWIRE

Stocks mentioned in the article
ChangeLast1st jan.
MEDTRONIC PLC -0.38% 111.42 Delayed Quote.-1.79%
SANUWAVE HEALTH, INC. -1.64% 0.1859 Delayed Quote.16.19%
THE PROCTER & GAMBLE COMPANY 0.66% 142.38 Delayed Quote.14.00%
share with twitter share with LinkedIn share with facebook
10/23ALPHABET, NETFLIX, TESLA : Stocks That Defined the Week
10/22THE PROCTER & GAMBLE COMPANY : Ex-dividend day for
10/20P&G raises forecasts on sustained demand for cleaning products
10/20PROCTER & GAMBLE : Oral-B Announces a New Initiative and $1 Million Commitment t..
10/20PROCTER & GAMBLE : Stocks moving higher on Wall Street following solid earnings
10/20GLOBAL MARKETS LIVE : Netflix, Google, Intel…
10/20PROCTER & GAMBLE : Q1 2021 Earnings Presentation
10/20PROCTER & GAMBLE CO : Regulation FD Disclosure, Financial Statements and Exhibit..
10/20PROCTER & GAMBLE CO : Gets a Neutral rating from RBC
10/20PROCTER & GAMBLE : Q1 2021 Earnings Release
More news
Financials (USD)
Sales 2021 74 113 M - -
Net income 2021 14 219 M - -
Net Debt 2021 18 744 M - -
P/E ratio 2021 25,9x
Yield 2021 2,27%
Capitalization 353 B 353 B -
EV / Sales 2021 5,02x
EV / Sales 2022 4,86x
Nbr of Employees 99 000
Free-Float 61,8%
Duration : Period :
The Procter & Gamble Company Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends THE PROCTER & GAMBLE COMPANY
Short TermMid-TermLong Term
Income Statement Evolution
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 151,55 $
Last Close Price 142,38 $
Spread / Highest target 19,4%
Spread / Average Target 6,44%
Spread / Lowest Target -22,0%
EPS Revisions
David S. Taylor Chairman, President & Chief Executive Officer
Jon R. Moeller Vice Chairman, Chief Operating & Financial Officer
Kathleen B. Fish Chief Research, Development & Innovation Officer
Vittorio Cretella Chief Information Officer
W. James McNerney Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
UNILEVER N.V.-0.25%158 938